Some results suggest involvement of Cav-1 in resistance to cancer treatments (Sekhar et al., 2013, as reviewed in Ketteler and Klein, 2018), and in tumor spreading (reviewed in Senetta et al., 2013; Campos et al., 2019). Here, CAV1 is linked to cancer.